Pfizer Oncology Company Profile
Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers, including breast, lung, prostate, sarcoma, melanoma, and various hematologic cancers. Pfizer Oncology has biologics and small molecules in clinical development and more than 200 clinical trials underway. By working collaboratively with academic institutions, individual researchers, cooperative research groups, governments, and licensing partners, Pfizer Oncology strives to cure or control cancer with breakthrough medicines, to deliver the right drug for each patient at the right time. For more information please visit www.Pfizer.com.
News Articles
VLST expands into oncology with clinical-stage Pfizer antibody
The private US biotechnology firm VLST has added oncology to its list of targeted disease areas, on top of autoimmune and inflammatory disorders, by in-licensing the anti-CD40 monoclonal antibody CP-8...
CytomX partners with Pfizer to develop Probody drug conjugates in oncology
Biotechnology company CytomX Therapeutics has signed a strategic agreement with Pfizer for the development and commercialisation of multiple Probody drug conjugates (PDCs) in the field of oncology.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Geno Germano, President and General Manager, Specialty Care and Oncology, at the G...
Pfizer's Oncology Division Gets A Boost With European Approval For Bosulif
By Trefis: The European Medicine Agency (EMA) has conditionally approved Pfizer’s (NYSE:PFE) Bosulif as a second-line treatment in certain chronic myelogenous leukemia (a type of white blood cel...
Pfizer in a licensing pact with VLST Corporation
VLST Corporation announced an in-licensing agreement with Pfizer Inc. for an anti-CD40 monoclonal antibody. CP-870,893 is a potent CD40 agonist that has been evaluated in a number of preclinical and c...
Return to top 50 pharma list Summary Website: Pfizer Headquarters: New York, USA Ticker: PFE (NYSE) SEC: Pfizer Recent deal news: Pfizer deal news at Current Partnering Must read report: Partne...
UPDATE 2-US FDA approves Pfizer leukemia drug
WASHINGTON, Sept 4 (Reuters) - U.S. health regulators on Tuesday approved a Pfizer Inc p ill f or a rare type of leukemia, another step in the company's effort to expand its oncology business.
Pfizer partnering activity 2005-2013
Pfizer announced over 410 partnering / licensing deals since 2005, with 59 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology, infectives, centra...
Drugs and Medications
Preparation h [Pfizer Consumer Healthcare]
Preparation H Suppositories(cocoa butter and phenylephrine HCl)
Chapstick overnight [Pfizer Consumer Healthcare]
ChapStick Overnight Lip Treatment (dimethicone)
Preparation h [Pfizer Consumer Healthcare]
Preparation H Hemorrhoidal Ointment (mineral oil, petrolatum and phenylephrine HCl)
Anbesol cold sore therapy [Pfizer Consumer Healthcare]
Anbesol Cold Sore Therapy(allantoin, benzocaine, camphor, and white petrolatum)
Chapstick lipshield 365 [Pfizer Consumer Healthcare]
Chapstick LipShield 365(avobenzone, dimethicone, homosalate, octinoxate, octisalate, and oxybenzone)
PubMed Articles
Reply to: Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.
Causal reasoning on biological networks: interpreting transcriptional changes.
The interpretation of high-throughput datasets has remained one of the central challenges of computational biology over the past decade. Furthermore, as the amount of biological knowledge increases, i...
Clinical Trials
The primary objective of the study is to determine bioequivalence of 50 mg (2x25 mg) Artesunate Sachet (Pfizer) versus 50 mg (1x50 mg) tablet, Arsuamoon® (Guilin China) which is the World...
Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
The purpose of this study is to demonstrate the safety and benefit of auto-transfusion filtered blood in patients undergoing major surgical oncology procedures.
The study will determine if amodiaquine tablet (Pfizer), an antimalaria agent, is pharmaceutically equivalent to a comparator product (Arsuamoon-Guilin China).
Cephalic Phase of Oncology Patients Before and After Chemotherapy as Compared to Healthy Controls
The objective of this trial is to examine the cephalic phase insulin response (CPIR) and pancreatic polypeptide (PP) release as indicators of the cephalic phase occurrence and magnitude to...
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
RATIONALE: Developing a way to track patients enrolled in Children's Oncology Group studies will help doctors gather long-term follow-up information and may help the study of cancer in the...
Companies
Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline, one of the most...
Historical High-Lights: Founded in 1972 as a subsidiary of Pfizer Inc. Ownership transferred from Pfizer Inc. to local institutions and the general public in 1993. Company name subsequently changed fr...
Pfizer Ophthalmics, a division of Pfizer Inc, is committed to preserving sight and eliminating preventable blindness. Pfizer Ophthalmics discovers, develops and provides leading treatments in ophthalm...
Centrum Silver
Bristol-Myers Squibb Company & Pfizer Inc.
In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-M...
More Information about "Pfizer Oncology" on BioPortfolio
We have published hundreds of Pfizer Oncology news stories on BioPortfolio along with dozens of Pfizer Oncology Clinical Trials and PubMed Articles about Pfizer Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pfizer Oncology Companies in our database. You can also find out about relevant Pfizer Oncology Drugs and Medications on this site too.
